Abstract. Activation of Wnt signaling without mutation of β-catenin or APC occurs frequently in human gastric cancers. Secreted frizzled-related protein (SFRP), a negative modulator of the Wnt signaling pathway, are frequently inactivated in human gastric cancers. Inhibition of SFRP gene expression may account for the Wnt/β-catenin activation in human gastric cancer. However, the molecular mechanisms of silencing of SFRP genes are not fully understood. Sodium butyrate, a histone deacetylase (HDAC) inhibitor, is known to exhibit anti-cancer effects partly through the differentiation of various cancer cells. In the present study, we investigated: i) the relationship between the silencing of SFRP genes and Wnt signaling; ii) the mechanism of sodium butyrate mediated epigenetic regulation of SFRPs expression in human gastric cancer. We observed that nuclear β-catenin was significantly increased in gastric cancer tissues as compared to adjacent non-cancerous tissues. Nuclear β-catenin accumulation and SFRP promoter methylation in human gastric cancer cells were noted. Treatment with the DNA methyltransferase inhibitor, 5'-Aza-2-deoxycytidine (5'-Aza-dC) rapidly restored SFRPs expression. Sodium butyrate (NaB) induced demethylation and histone modification at the promoter region of SFRP1/2 restoring the SFRP expression in human gastric cancer cells. Analysis of general expression revealed that overexpression of SFRPs repressed Wnt target gene expression and induced changes in the proliferation and apoptosis related genes in human gastric cancer cells. These data suggest that aberrant epigenetic modification of SFRP genes is one of the major mechanisms by which Wnt signaling is activated in human gastric cancer cells and sodium butyrate may modulate the SFRP1/2 expression through histone modification and promoter demethylation causing anti-tumor effects.
Introduction
Epigenetic mechanisms have crucial roles in the control of gene activity and nuclear architecture. The most widely studied epigenetic modification in humans is the cytosine methylation of DNA within the dinucleotide CpG; 3-6% of all cytosines are methylated in normal human DNA (1) . Silencing of cancerassociated genes by hypermethylation of CpG islands within the promoter regions is a common feature of human cancer and is often associated with partial or complete transcriptional block (2) . Histone modifications are another key player in epigenetics (3) . Promoter CpG-island hypermethylation in cancer cells is known to be associated with a particular combination of histone marks: deacetylation of histones H3 and H4, loss of histone H3 lysine K4 (H3K4) trimethylation, and gain of H3K9 methylation and H3K27 trimethylation (4, 5) . Histone modifications are recognized as playing a crucial role in regulation of gene expression and chromatin structure and are closely involved with DNA methylation. These processes have been shown to be involved in the inactivation of many tumor suppressor genes (6, 7) .
Two Wnt signaling pathways have been elucidated: the canonical and non-canonical pathways. Activation of the canonical pathway is mediated by β-catenin and the non-canonical pathway by β-catenin independent factors. Generally, in the absence of signal stimulation, β-catenin protein is destabilized by a cytoplasmic complex containing the proteins Axin, adenomatous polyposis coli (APC), and glycogen synthase kinase-3β (GSK-3β) (8, 11) . Activation of Wnt signaling results in accumulation of stabilized β-catenin, which activates transcription of target genes via a complex with T-cell factor/lymphocyte enhancing factor families of transcription factor (TCF/LEF) after nuclear translocation (9, 12) . On the other hand, the canonical Wnt signaling pathway is negatively regulated by a multitude of soluble factors in the extracellular milieu. These include: Wnt inhibitory factor 1 (WIF1), secreted Frizzled related proteins (SFRPs), and Dickkopf (DKK) family of secreted proteins, which antagonize Wnt signaling by binding to LRP5/6 component (co-receptors for Frizzled) of the Wnt receptor complex Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: Induction of promoter demethylation and histone modification causing inhibition of Wnt signaling (9) . WIF1 encodes a secreted protein with a unique and highly conserved WIF domain and five epidermal growth factor-like repeats, which bind to Wnt proteins and inhibits their activities (10) . In humans, the SFRP family consists of 5 members, each containing a cysteine-rich domain (CRD) which shares 30-50% sequence homology with the CRD of Frizzled receptors (13) (14) (15) . In addition to sequestrating Wnt ligands, SFRPs also downregulate the Wnt signaling pathway by the formation of inhibitory complex with Frizzled receptors (13) (14) (15) . Sodium butyrate (NaB), a short chain fatty acid, occurs naturally in the body from the acetyl-CoA dependent catabolic oxidation of long chain saturated fatty acids (16, 17) . Sodium butyrate as a histone deacetylase (HDAC) inhibitor is known to exhibit anti-cancer effects via the differentiation of various carcinoma cells (18) (19) (20) (21) . In this study, we aimed at elucidation of the epigenetic mechanism involved in SFRP expression, and the effect of sodium butyrate on SFRP expression in human gastric cancer cells.
Materials and methods
Cell culture and treatments. A total of nine human gastric cancer cell lines (AGS, KatoⅢ, MKN28, MKN45, MKN74, NCI-N87, SNU-1, SNU-16, and NCI-N87) were obtained from Korean Cell Line Bank (Korea) and American Type Culture Collection (Manassas, VA, USA). Cells were cultured in RPMI-1640 medium (Hyclone Laboraloties, Inc. USA) containing 10% fetal bovine serum (Hyclone) and 1% penicillin streptomycin sulfate (Hyclone) at 5% CO 2 , 37˚C and 95% humidity.
Sodium butyrate, 5'-Aza-2-deoxycytidine (5'-Aza-dC), and Trichostatin A were purchased from Sigma-Aldrich (St. Louis, MO). Working concentrations used were as follows: butyrate, 2 µM; 5-Aza-dC, 2 µM; and Trichostatin A, 200 nM respectively.
Tissue samples and immunohistochemistry. Surgical specimens were obtained from 20 patients with gastric cancer with associated clinical information. The cases were provided by the Gastrointestinal Tumor Working Group Tissue Bank, Yonsei University Medical Center (Seoul, Korea) between December 1996 and December 2004. Authorization for the use of tissue for research purposes was obtained from the Institutional Review Board of Yonsei University Health System. Tissue sections in micro-slides were deparaffinized with xylene, hydrated in serial dilutions of alcohol, and immersed in 3% H 2 O 2 . Following antigen retrieval in citrate buffer (pH 6.0), the tissue sections were incubated with protein blocking agent (Immunotech, Coulter, Inc, Marseille, France) to block non-specific antibody binding for 20 min at room temperature and then incubated overnight at 4˚C with respective primary polyclonal goat antibodies against human β-catenin (Santa Cruz). After washing with PBS three times, the sections were incubated with a biotinylated secondary antibody (goat anti-rabbit IgG, Immunotech) and streptavidin conjugated to horseradish peroxidase (Immunotech) for 20 min at room temperature, followed by a PBS wash. The chromogen was developed for 5 min with liquid 3,3'-diaminobenzidine (Immunotech). Next, slides were counterstained with Meyer's hematoxylin. Expression status was quantified by scoring both the intensity and proportion of β-catenin staining. The intensity of nuclear β-catenin staining was scored as 0, negative (weak or similar to background); 1, weak (less intense than normal cells); 2, moderate (similar intensity to normal cells); and 3, strong (stronger than normal cells). The proportion of expression in each tissue was determined by counting positively stained cancer cells in relation to a total of three hundred cells, and expressing the result as a percentage.
RNA isolation, reverse transcription, polymerase chain reaction. Total RNA from human gastric cancer cells were prepared using TRIzol reagent (Invitrogen). The RNA was reverse transcribed using oligo (dT) primers and Superscript™ Ⅱ reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Primers used for PCR amplification of this cDNA were for SFRP1: forward 5'-TCA TGC AGT TCT TCG GCT TC-3' and reverse 5'-CCA ACT TCA GGG GCT TCT TCT TC-3'; SFRP2: forward 5'-TCT CCT ACA AGC GCA GCA AT-3' and reverse 5'-GAA CTT CTT GGT GTC CGG GT-3'; β-actin: forward 5'-TTG CCG ACA GGA TGC AGA AG-3' and reverse 5'-AGG TGG ACA GCG AGG CCA GG-3'. PCR reactions were employed using PCR Maxi kit (iNtRON, Sungnam, Korea). PCR reactions in the linear range of amplification were analyzed by agarose gel electrophoresis and quantified by densitometry if needed. Western blot analysis. Prepared cells were harvested after washing with PBS. Collected cells were lysed with buffer [50 mM Tris-Cl (pH 7.5), 150 mM NaCl, 1 mM EDTA (pH 8.0), 1% Triton X-100, 1 mM PMSF, 1 mM Na 3 VO 4 , and protease inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN, USA)]. Fractionation was performed by sequential extraction of cytosolic and nuclear proteins in nonionic detergent for analysis of β-catenin. The same amount of protein was boiled at 95˚C after adding SDS sample buffer [62.5 mM Tris-Cl (pH 6.8), 2% sodium dodecyl sulfate, 10% glycerol, β-mercaptoethanol, and 0.002% bromophenol blue]. Samples were loaded in 12% SDS-PAGE gels for SFRP1/2, 10% SDS-PAGE gels for β-catenin and then transferred to PVDF membranes (Amersham Biosciences, Pisctaway, NJ, USA). Anti-SFRP1 (Santa Cruz), Anti-SFRP2 (Santa Cruz), anti-β-catenin (Santa Cruz) was used as the primary labeling antibodies and the appropriate horseradish peroxidase-conjugated antibodies (Santa Cruz) were used as secondary antibodies. An enhanced chemiluminescence detection system (ECL-Plus, iNtRON) was used for the detection according to the manufacturer's protocol.
TCF/LEF reporter assay.
Reporter assays with pGL3-OT, a TCF/LEF-responsive luciferase reporter plasmid, and pGL3-OF, a negative control plasmid, were carried out as described previously (22) . Briefly, cells (1x10 4 cells/well in 12-well plates) were transfected with 100 ng of pGL3-OT or pGL3-OF and 2 ng of pGL-TK using Lipofectamine 2000 (Invitrogen). For co-transfection experiments, cells were transfected with 500 ng of pCMV-HA-SFRP1 or pCMV-HA-SFRP2 vectors kind gift by Dr H. Suzuki (Department of Internal Medicine, Sapporo Medical University) plus the reporter plasmid. Firefly and renilla luciferase activities were measured 48 h the after transfection using a Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) according to the manufacturer's instruction.
Flow cytometry. Cells were treated with 2 µM sodium butyrate (Sigma), 2 µM 5'-Aza-dC (Sigma), and 200 nM Trichostatin A (Sigma) for 48 h, replacing the drug and medium every 24 h. Prepared cells were harvested after washing with PBS. Collected cells were lysed with 1X binding buffer (BD Bioscience, USA). Then, 100 µl of the lysate were transferred to a 5-ml culture tube and treated with FITC Annexin V and PI (BD Bioscience) for 15 min at 25˚C in dark. The cell cycle distribution was determined using a FACScan flow cytometer (Becton-Dickinson, Mountain View, CA, USA) and 10,000 cells were analysed with MultiCycle software package (Phoenix, San Diego, CA, USA).
Cell proliferation assay. Cells were seeded in 96-well plates. Cells were treated with 2 µM sodium butyrate (Sigma), 2 µM 5'-Aza-dC (Sigma), and 200 nM Trichostatin A (Sigma) for 48 h, replacing the drug and medium every 24 h. The colorimetric MTTs (Promega) assay was used to measure viable cell numbers at 48 h. Experiments were performed in triplicates.
Immunofluorescence microscopy. Cells cultured on chamber slides were washed with phosphate buffered saline (PBS) and fixed with 10% formaldehyde, after which they were incubated with anti-β-catenin monoclonal antibody, anti-SFRP1 and anti-SFRP2 (Santa Cruz) and stained with anti-mouse IgG-FITC (Santa Cruz), anti-goat IgG-TR (Santa Cruz). Cells were visualized using a Zeiss LSM 510 confocal laserscanning microscope (Carl Zeiss, USA).
Chromatin immunoprecipitation (ChIP) assay. ChIP analysis was done using ChIP assay kit (Upstate Biotechnology, Inc.) according to the manufacturer's instructions. AGS and MKN45 cells were used. Immunoprecipitation was done overnight at 4˚C with 10 µl of the sample used as the input, or 1 µg of AcH3 (AcH3, 06-599, Upstate Biotechnology, Lake Placid, NY, USA), AcH4 (AcH4, 06-866, Upstate Biotechnology), H3K4 (07-030, Upstate Biotechnology), H3K9 (AB1220, Abcam, Cambridge, MA, USA) or the negative control mouse IgG, positive control anti-RNA polymerase beads. After reverse cross-linking, DNA was purified with QIAquick PCR purification kit (Qiagen) from the immunoprecipitates.
Primers were designed to separately amplify regions in the SFRPs promoter are SFRP1: forward, 5'-GTT GGA GCT GTT TGC TGT GA-3' and reverse, 5'-ATG TTT TGG CTT TCC ACA CC-3'; SFRP2: forward, 5'-AAA AAG GCC AAG AAA ACT CT-3' and reverse, 5'-CGG AGT TCG AGC TTG TCC-3' (46).
Statistical analysis.
Statistical significance was evaluated using Student's t-test and Pearson's χ 2 test for immunohistochemistry, Student's t-test for luciferase activity, cell apoptosis, proliferation and a One-way ANOVA with multiple comparison tests for densitometry analysis. P<0.05 was considered statistically significant. To confirm the induction results, experiments were repeated at least three times. All statistical analyses were carried out using SPSS 12.0 software (SPSS, Chicago, IL, USA).
Results

Wnt signaling pathways in human gastric cancer cell lines and tissues.
To evaluate the Wnt signal expression in gastric cancer tissues, immunohistochemical staining was carried out for 20 paraffin-embedded surgical specimens. All specimens were obtained from gastric cancer patients with American Joint Committee on Cancer (AJCC) TNM stage I or II. Nuclear β-catenin expression was higher in cancer tissues than adjacent non-cancerous tissues (Fig. 1A and Table I ). We also determined the correlation between H. pylori infection and SFRP1/2 methylation from the endoscopically biopsied clinical tissues. H. pylori infection was detected in gastric cancer tissues irrespective of methylation status of SFRP1/2 genes. There was no association between promoter hypermethylation of SFRP1/2 gene and the status of H. pylori infection. In addition, there was no significant association between SFRP1/2 methylation and the clinicopathological characteristics of cancer including age, sex, and Table I . Expression of nuclear β-catenin in human gastric cancer. The positive rate of expression was determined by counting the number of tissues to have positively stained cancer cells in 10 specimens of each tissue. The intensity was scored as 0, no detectable nuclear staining; 1, weak nuclear staining; or 2, strong nuclear staining. The number of positively stained cancer cells in relation to a total of a hundred cells was multiplied by the intensity score (0, 1 or 2), and then was added up (mean ± SD).
prognosis for patients (Table II) . To investigate activation of the canonical Wnt signaling pathway in human gastric cancer cell lines, the expression of nuclear β-catenin proteins was assessed by Western blotting after sequential extraction of cytosolic and nuclear proteins from cells (Fig. 1B) . We found expression of nuclear β-catenin in eight of the nine cells, although the levels of expression varied among the cell lines (Fig. 1B) . Thus, these finding suggest the involvement of mechanisms other than alterations in gene expression of APC or β-catenin in the activated of Wnt signaling in human gastric cancer.
Expression and methylation status of SFRPs in human gastric
cancer cell lines. The down-regulation of SFRP gene expression may also contribute to the activation of Wnt signaling in human gastric cancer cell lines. We first used reverse transcriptase polymerase chain reaction (RT-PCR) to analyse SFRP expression in human gastric cancer lines. Surprisingly, none of the nine human gastric cancer cell lines tested showed any expression of SFRP1/2 mRNA. On the other hands treatment with a DNA methyltransferase inhibitor, 5'-Aza-dC rapidly restored SFRPs expression, strongly indicating the epigenetic silencing of SFRP1/2 in human gastric cancer cells (Fig. 2A) . The expression of SFRP1/2 in human gastric cancer cells also increased after NaB treatment (Fig. 2B) . These findings suggest that sodium butyrate treatment may also induce promoter demethylation of SFRP genes in human gastric cancer cells. To this end, we examined the status of SFRP promoter methylation. Our methylation specific PCR (MS PCR) analysis indeed revealed the methylation of SFRP1/2 in all 9 human gastric cancer cell lines (Fig. 2C) . These findings suggest that loss of SFRP gene expression is strongly associated with DNA methylation in human gastric cancer cell lines.
Decreased nuclear β-catenin by sodium butyrate. To investigate the changes in expression pattern of nuclear β-catenin by epigenetic modifiers in human gastric cancer cells, the nuclear β-catenin expression was assessed by Western blotting after sequential extraction of cytosolic and nuclear proteins from cells. The expression of nuclear β-catenin decreased without a change in cytoplasmic β-catenin during treatment with NaB, 5'-Aza-dC, TSA in human gastric cancer cells (Fig. 3A) . When TCF/LEF-regulated transcriptional activity in human gastric cancer cells were analysed using a TCF/LEF-responsive luciferase reporter vector (pGL3-OT), we found that the luciferase activity of pGL3-OT were more than twofold higher that of pGL3-OF, a negative control vector (Fig. 3B) . Treatment with NaB, 5'-Aza-dC and TSA significantly inhibited pGL3-OT activity. These findings indicated that effective inhibition of Wnt signal in human gastric cancer cells was achieved through the epigenetic regulation.
SFRP1 SFRP2 -------------------------------
Effect of sodium butyrate on SFRPs promoter methylation and histone modification.
To investigate the role of histone modification in the epigenetic inactivation of the SFRPs genes, we examined histone acetylation and methylation pattern in the chromatin associated with the SFRP1/2 promoter region using ChIP assay. The histone-associated DNAs, immunoprecipitated with antibodies against AcH3, AcH4, H3K4 and H3K9, were individually amplified with primer covering the SFRP1/2 promoter regions (Fig. 4A) . The ChIP assay showed marked increase in the levels of histone modification of SFRP1/2 gene in human gastric cancer cells. As sodium butyrate is a well know histone deacetylase (HDAC) inhibitor including histone modification epigenetically, we saught to determine whether DNA methylation changes also contributed to SFRP activation by the sodium butyrate. To that purpose, the methylations of the SFRP1/2 promoter were analyzed with methylation specific PCR in human gastric cancer cell lines (Fig. 4B) . We found that sodium butyrate treatment also induced promoter demethylation of SFRP genes in human gastric cancer cells along with histone modification as well. These finding suggest that sodium butyrate induces both promoter demethylation and histone modification epigenetically to activate SFRP gene expression in human gastric cancer cells.
Inhibition of the nuclear β-catenin expression by sodium butyrate treatment. To confirm the crosstalk between the nuclear β-catenin and SFRPs expression by sodium butyrate, immunofluorescence assay were performed in human gastric cancer cells 48 h after the treatment with sodium butyrate. Decreased nuclear β-catenin expression and increased SFRP expression was noted by sodium butyrate. These finding suggest that the increased SFRP expression correlated with the deceased nuclear β-catenin localization in sodium butyrate treated human gastric cancer cells (Fig. 5) .
Suppression of TCF/LEF activity by SFRP overexpression.
SFRP1/2 expression vector was transiently transfected to human gastric cancer cells (AGS and MKN45) with silencing of SFRP1 and 2. After 48 h of transfection, TCF/LEF activity was significantly decreased from 40% (AGS: SFRP1) ( * P<0.05), 37% (AGS: SFRP2) ( * P<0.05), 33% (MKN45: SFRP1) ( * P<0.05), Figure 5 . Decreased nuclear β-catenin expression due to butyrate treatment in human gastric cell lines. Immunofluorescence assay of the intracellular distribution of β-catenin in human gastric cell lines. Cells were stained with anti-β-catenin antibody (green) and anti-SFRP1/2 antibody (red). Nuclei were visualized using 40,6-diamidino-2-phenylindole (DAPI, blue). Figure 6 . The Wnt signaling pathway in human gastric cancer cells can be suppressed by overexpression of SFRPs. Relative luciferase activity obtained using a TCF/LEF-responsive reporter (pGL3-OT) and a negative control (pGL3-OF) in GC cells transfected with the indicated SFRP1/2 expression constructs. Results are expressed as the pGL3-OT/pGL3-OF activity ratio after correction for transfection efficiency using renilla luciferase activity. Shown are means of four replications; the error bars represent standard deviations.
35% (MKN45: SFRP2) ( * P<0.05). These finding suggest that overexpression of either SFRP1 or SFRP2 suppressed TCF/LEF activity in human gastric cancer cells (Fig. 6 ). (Fig. 7) as determined by cell proliferation assay. Cell apoptosis were also determined by counting sub-G1 phase cells in flow cytometry analysis. At 48 h of sodium butyrate treatment, cell apoptosis was significantly induced from 0.6 to 13.1% (in AGS) and 0.1 to 19.6% (in MKN45) respectively ( * P<0.05) (Fig. 8A ). Also at 48 h of SFRP overexpression by plasmid transfection, cell apoptosis was significantly induced from 0.06 to 23.4% (in AGS) and 0.04 to 14.1% (in MKN45) ( * P<0.05) (Fig. 8B) . These findings suggest that SFRP, as a tumor suppressor, inhibits cell proliferation and induces cell apoptosis in human gastric cancer.
Discussion
Several lines of evidence suggest the activation of the Wnt signal pathway also occurs in gastric cancer cell lines with varying degree of APC or β-catenin gene mutations (12) (13) (14) (15) . It was reported that 19.5% (59 of 303) of primary gastric cancer showed nuclear accumulation of β-catenin while β-catenin mutation was detected in only 5% (4 of 77) of the cancers (37) (38) (39) . Another group analysed 311 primary gastric cancers and observed nuclear β-catenin in 90 (29%), but β-catenin mutations in only 19 of 73 cancers (26%) with nuclear β-catenin, and no mutations were found in 19 β-catenin without nuclear accumulation (17, 38) .
In this study, we first sought to assess the role of Wnt signaling in human gastric cancer cells using several independent approaches. Using immunohistochemistry staining, we observed that nuclear β-catenin expression was higher in cancer tissues than adjacent non-cancer tissues by immunohistochemical examination of clinically cancer tissues. Western blot analysis showed detectable levels of β-catenin in human gastric cancer cells tested. However, the levels of nuclear β-catenin expression were much more varied and were not detected in one cell line (SNU1). These results suggested that the involvement of mechanisms other than Wnt related gene mutations in the activation of Wnt signaling in human gastric cancer cells. Hypermethylation can suppress the expression of important growth regulatory genes. Although the process driving aberrant methylation is not clear, it has been proposed that tissue inflammation and elevated rates of cell turnover may play an important role (18) (19) (20) (31) (32) (33) . SFRPs were down-regulated in human gastric cancer and may carry tumor suppressor potential (21, 23, 24, 40) . The putative function of SFRPs as antagonist of the Wnt pathway provides a potential mechanism to suppress the abnormal activation of this pathway in vivo. To this end the evaluation of mechanisms of down-regulation of SFRP expression may also contribute to the suppression of Wnt signaling in human gastric cancer providing a potential anti-tumor target. We extended the study to determine the mRNA expression level and the methylation status of SFRPs in human gastric cancer. Surprisingly, none of the 9 human gastric cancer cell lines tested showed any expression of SFRP1/2 mRNA. Treatment with a DNA methyltransferase inhibitor, 5'-Aza-dC rapidly restored SFRPs expression. We observed SFRP methylation in all the human gastric cancer cell lines tested. These data suggested that alterations in SFRP1/2 may also be important determinants of the Wnt signaling in human gastric cancer (12, (25) (26) (27) .
Various compounds have been shown to impact methylation, raising the possibility that an individual's diet may also influence DNA methylation (28) (29) (30) 33) . Sodium butyrate is generated by the microbial metabolism of dietary fibers in the lower gastrointestinal tract and has been proposed to confer a number of health benefits including a reduced risk of colorectal cancer (31, 32, 41) . Here, we report that the sodium butyrate can reactivate SFRP expression in human gastric cancer cells, through epigenetic mechanism. Using western blot analysis significant change of total β-catenin level by sodium butyrate treatment in human gastric cancer cells was tested, and levels of nuclear β-catenin expression were siginificantly decreased in human gastric cancer cell lines. TCF/LEF-regulated transcription activity showed that β-catenin-TCF/LEF activity deceased with sodium butyrate treatment or SFRP overexpression. Immunofluorescence analysis showed the increased SFRP expression and suppression of nuclear β-catenin expression in sodium butyrate treated human gastric cancer cells. These findings suggest inhibition of the nuclear β-catenin translation and increased SFRP expression by sodium butyrate in human gastric cancer. Several tumor suppressor genes are known to be repressed by hypomethylated promoters (33, 34) . These facts indicate that although DNA methylation is a major epigenetic mechanism for gene silencing, there are other epigenetic silencing pathways independent of DNA methylation (35) . It is generally accepted that aberrant DNA methylation and histone modifications work together to silence many tumor suppressor genes in human cancer (36, 37) . ChIP assay revealed that histone modification indeed were increased in human gastric cancer cells. These histone patterns are known as an open chromatin structure with associated with active gene expression. We examined the effect of a sodium butyrate on histone acetylation (AcH3, AcH4), H3K4 and H3K9 methylation associated with the SFRP1/2 promoter regions along with the effect of sodium butyrate on SFRP methylation status in human gastric cancer.
Our data suggested that: i) sodium butyrate cause SFRP promoter demethylation; generated a more sporadic pattern of demethylation; ii) DNA methylation and histone modifications of SFRP promoter region were strongly correlated with SFRP expression in human gastric cancer. Wnt signal activation by mutant β-catenin or APC could be suppressed partially by overexpression of SFRPs (38) (39) (40) 42, 43) . One recent study showed that SFRP1 is frequently methylated in prostate cancer, and ectopic expression of SFRP1 reduced cellular proliferation, even though β-catenin-TCF/LEF is not activated in prostate cancer cells (44) . In another study, SFRP4 was found to be methylated in β-catenin-deficient mesothelioma cells, and overexpression of SFRP4 in the cells resulted in apoptosis and growth suppression (45, 46) . We obtained similar results that expression of SFRPs in human gastric cancer cell lines inhibits cell proliferation and induces cell apoptosis. Our results suggest that the activation of Wnt signaling may occur without mutation of β-catenin or APC genes and this may be induced by down-regulation of SFRP in human gastric cancer cells. We found that human gastric cancer cells showed increased Wnt signal activity and the SFRP expression was down-regulated through epigenetic modification. Sodium butyrate did not complete demethylation but generated a more sporadic pattern of demethylation. DNA methylation and histone modifications at the SFRP promoter region were strongly correlated with SFRPs expression. Expression of SFRPs likely contributes to the proliferation and apoptosis of human gastric cancer cells. In conclusion, DNA methylation and histone modification act together to inhibit SFRP gene expression in human gastric cancer cell lines. Sodium butyrate may prove to be considerably effective at preventing cancer-induced changes in DNA methylation.
